Fazio–Londe disease

From WikiMD's WELLNESSPEDIA

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Fazio–Londe disease
Synonyms Progressive bulbar palsy of childhood
Pronounce N/A
Specialty Neurology
Symptoms Dysphagia, dysarthria, facial weakness, respiratory failure
Complications N/A
Onset Childhood
Duration Progressive
Types N/A
Causes Genetic mutations in the SLC52A3 gene
Risks Family history of the disease
Diagnosis Genetic testing, clinical examination
Differential diagnosis Amyotrophic lateral sclerosis, Kennedy disease
Prevention N/A
Treatment Supportive care, respiratory support
Medication N/A
Prognosis Variable, often poor
Frequency Rare
Deaths N/A


Fazio–Londe disease is a rare, inherited neurological condition. It is also known as progressive bulbar palsy of childhood. The disease is characterized by progressive weakness and wasting (atrophy) of the muscles that control movement (motor neurons).

Symptoms[edit]

The symptoms of Fazio-Londe disease typically begin in childhood or adolescence. The most common initial symptoms are difficulty speaking (dysarthria) and difficulty swallowing (dysphagia). As the disease progresses, it affects the muscles of the face, throat, and tongue, leading to additional problems with speech, chewing, and swallowing.

Causes[edit]

Fazio-Londe disease is caused by mutations in the SLC52A3 gene. This gene provides instructions for making a protein that is involved in the transport of certain vitamins into cells. Mutations in the SLC52A3 gene disrupt this transport, which can lead to the death of motor neurons.

Diagnosis[edit]

Diagnosis of Fazio-Londe disease is based on the clinical symptoms, a detailed patient history, a thorough clinical evaluation, and a variety of specialized tests. Genetic testing can confirm a diagnosis.

Treatment[edit]

There is currently no cure for Fazio-Londe disease. Treatment is symptomatic and supportive. Physical therapy, occupational therapy, and speech therapy may be beneficial.

Prognosis[edit]

The prognosis for individuals with Fazio-Londe disease varies. Some individuals have a normal life span with slow disease progression. Others may experience serious complications such as respiratory failure.

See also[edit]

References[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.